Home

Applications

APPLICATIONS OVERVIEW
DRUG DISCOVERY
ADME-Tox
Biochemical Assays
Cell-based Assays
HTS and Secondary Screening
Microsampling
Protein Crystallography
RNAi
Sample Management
CANCER RESEARCH
Personalized Medicine
Functional Screening / DSRT
RNAi
Sequencing
Single-cell Genomics
GENOMIC RESEARCH
Gene Expression
Genotyping
Microbiome
qPCR
Sequencing
Single-cell Genomics
Synthetic Biology

Products

LIQUID HANDLING
LIQUID HANDLERS OVERVIEW
Echo® 525 Liquid Handler
Echo® 555 Liquid Handler
Echo® 550 Liquid Handler
Echo® 520 Liquid Handler
AUTOMATION
AUTOMATION OVERVIEW
Access™ Laboratory Workstation
Tempo™ Automation Control Software
SOFTWARE APPLICATIONS
SOFTWARE OVERVIEW
Echo® Array Maker
Echo® Cherry Pick
Echo® Combination Screen
Echo® Compliance Manager
Echo® Dose-Response
Echo® Plate Audit
Echo® Plate Reformat
CONSUMABLES
CONSUMABLES OVERVIEW
Echo® Qualified Microplates
Labcyte® Assay Microplates
MicroClime® Environmental Lid
Echo® Qualified Reservoir

Technology

Echo® Acoustic Liquid Handling
Dynamic Fluid Analysis™
Direct Dilution

News / Events

Labcyte BLOG
Upcoming Events
Press Releases
Labcyte in the News
Labcyte Community

Resources

JALA Special Issue
Publications
Articles and Other Media
Application Notes
Posters
Webinars
Videos
Customer Profiles
Core Labs

Support

Brochures
Web Documentation*
User Guides*
Quick Start Guides*
Specification Sheets
Site Prep Guides
Service and Maintenance
Request Information

Company

About Us
Echo® Acoustic Technology
Leadership Team
Meet Labcyte
Careers
Contact and Location
Privacy Policy

Labcyte BLOG

Interview: Rob Knight from UCSD Talks Microbiome with Mendelspod
THURSDAY, JULY 06, 2017
linkedin twitter facebook |  9Shares

In a recent Mendelspod podcast, you can hear an interview with Labcyte customer Dr. Rob Knight about progress in understanding the microbiome. Dr. Knight, Professor and Founder of the Center for Microbiome Innovation at UC San Diego, is well known for his microbiome research, including work showing that the microbiome of lean mice differed from those of obese mice.


According to Dr. Knight, there are still a lot of questions to answer in the microbiome, but he feels it’s “one of the most exciting frontiers in science.” For example, we know that human genomes are 99.99 percent the same, but our microbiomes can differ by 80-90 percent, “so there’s a lot of variation out there to explain, explore and exploit,” he says.


Dr. Knight relies on platform technologies that “can go wherever the science leads us,” he says. One of these platform technologies is the Echo® Liquid Handler.


“Were very excited about acoustic liquid transfers and it’s certainly true that advances in liquid handling are crucial for metagenomics in high throughput,” says Dr. Knight. “Overall our improved liquid handling pipeline has been transformative for being able to shotgun metagenomics at scale, which we’re now doing a lot of.”


Dr. Knight sees tremendous potential for taking control over our microbiomes, including “an improved user interface to the microbiome”’ that will make it accessible to anyone. Head over to Mendelspod to hear the full interview.